2m 2m 2m 2m 2m 2m 2m
PELTHOS THERAP (PTHS)
NYSE
$25.86-$0.14 (-0.54%)
Price as of Jun 03, 2026 4:10 PM EDT- $92.0MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
PELTHOS THERAP (PTHS)
$25.86-$0.14 (-0.54%)
PTHS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.00 | ||
Change | -$0.20 (-0.76%) | ||
Open | $26.73 | ||
High | $26.73 | ||
Low | $25.91 | ||
Previous Close | $26.20 | ||
Volume | 6,184 | ||
30-Day Average Volume | 22,938 | ||
1-Week Change | -4.31% | ||
1-Month Change | 4.00% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.5M | ||
Total Assets | $145.4M | ||
Market Cap | $92.0M | ||
Enterprise Value | $122.4M | ||
Period: QTR TTM FY | |||
Revenue | $10.7M | ||
Net Income | -$10.2M | ||
Free Cash Flow | -$13.3M | ||
EBIT | -$10.2M | ||
EBITDA | -$9.2M | ||
Net Working Capital | $44.8M | ||
EPS | -$3.09 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 3 | ||
P/E | -9 | ||
PEG | N/A | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue